PREDIDIAB PRÉDIRE POUR PRÉVENIR
Live / Allowed — Published for opposition (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Jan 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79419015
- Mark type
- Design + words
- Filed
- 17 Jan 2025
- Published for opposition
- 10 Mar 2026
- Attorney of record
- Andrew D. Bochner
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for the treatment of diabetes; pharmaceutical and veterinary preparations, namely, medicinal preparations for regulating blood sugar and improving glucose metabolism, dietary supplements, dietetic food adapted for medical use, sanitary preparations for medical purposes; sanitary products for medicine being sanitary sterilizing preparations; dietetic foods and beverages adapted for medical use; chemical reagents for medical and pharmaceutical use; vaccines; food for babies; medical plasters, gauze for dressings; disinfectants; vitamins, vitamin-based preparations being dietary supplements; natural dietetic foods based on medicinal plants for medical and veterinary use; nutritionally fortified beverages and foods for medicinal use; additives in the nature of dietary supplements for humans and for animals for medicinal use; mineral food supplements for medicinal use; nutritional supplements, plant-based dietary supplements for medicinal use; food supplements containing proteins, carbohydrates, lipids, fibers, and micronutrients, for medical use; plant extracts other than essential oils for medicinal use; preparations for making dietetic and medicated beverages, namely, powdered nutritional supplement drink mix and concentrate; medicinal preparations, namely, preparations for the treatment of diabetes; chemical preparations for medicinal use being chemical reagents for medical purposes; substances for medicinal use being medicinal drinks; medicated candy and confectionery for medicinal use; medicated pharmacological preparations for skin care; medical diagnostic products being diagnostic preparations for medical purposes; kit for detecting a risk of predisposition to diabetes being diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; chemical preparations for the diagnosis of diabetes being diagnostic preparations for medical purposes; pharmaceutical preparations for the prevention and treatment of diabetes
- Class 042 — Scientific and technological services: Scientific research, scientific investigations for medical purposes; technological consulting services for digital transformation new product development; industrial design; medical and pharmacological research services; development of pharmaceutical products for others; carrying out evaluations of pharmaceutical products being product quality evaluation services; carrying out testing on pharmaceutical products being product quality testing services; laboratory research services concerning pharmaceuticals; computer programming in the medical field; management of data for medical use being electronic data storage of medical data; information and advisory services relating to the aforesaid services; providing scientific research consultation and consultancy pertaining to pharmacology
Owner
Prosecution history
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 05 Mar 2026 — NOTIFICATION PROCESSED BY IB
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Feb 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 17 Feb 2026 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 10 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Aug 2025 — REFUSAL PROCESSED BY IB
- 13 Aug 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 12 Aug 2025 — REFUSAL PROCESSED BY MPU
- 28 Jun 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 27 Jun 2025 — NON-FINAL ACTION WRITTEN